Recent 13F filings as of December 2025 show that 31 institutional investors hold a position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 30 Sep, 2025 | 15,518,492 | 0 | 0.00% | $251,709,940.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 10,428,437 | 525,804 | 5.31% | $169,149,248.00 |
| BAKER BROS. ADVISORS LP | 30 Sep, 2025 | 7,305,940 | 0 | 0.00% | $118,502,347.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 6,351,487 | -429,559 | -6.33% | $103,021,118.00 |
| Paradigm Biocapital Advisors LP | 30 Sep, 2025 | 6,170,131 | 27,787 | 0.45% | $100,079,525.00 |
| Novo Holdings A/S | 30 Sep, 2025 | 5,350,000 | 0 | 0.00% | $86,777,000.00 |
| BRAIDWELL LP | 30 Sep, 2025 | 5,210,831 | 0 | 0.00% | $84,519,679.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 4,979,331 | -524,018 | -9.52% | $80,804,202.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 4,803,941 | -37,559 | -0.78% | $77,919,924.00 |
| Cormorant Asset Management, LP | 30 Sep, 2025 | 4,010,000 | -241,992 | -5.69% | $65,042,200.00 |
| Siren, L.L.C. | 30 Sep, 2025 | 3,897,099 | 736,801 | 23.31% | $63,210,946.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 3,795,894 | -844,055 | -18.19% | $61,569,401.00 |
| Bellevue Group AG | 30 Sep, 2025 | 2,775,997 | 0 | 0.00% | $45,026,671.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 2,228,285 | 126,504 | 6.02% | $36,142,783.00 |
| MPM BioImpact LLC | 30 Sep, 2025 | 1,720,741 | 0 | 0.00% | $27,910,419.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,717,641 | -79,574 | -4.43% | $27,864,280.00 |
| STATE STREET CORP | 30 Sep, 2025 | 1,699,909 | -81,592 | -4.58% | $27,572,524.00 |
| Integral Health Asset Management, LLC | 30 Sep, 2025 | 1,500,000 | 500,000 | 50.00% | $24,330,000.00 |
| First Light Asset Management, LLC | 30 Sep, 2025 | 1,414,994 | -299,025 | -17.45% | $22,951,203.00 |
| DIMENSIONAL FUND ADVISORS LP | 30 Sep, 2025 | 1,183,136 | 134,200 | 12.79% | $19,187,177.00 |